US FDA approves GSK's drug for liver disease related itching
GSK(US:GSK) Reuters·2026-03-19 12:08Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv Signage is pictured in the main lobby of GSK offices in London, Britain, February 20, 2025. REUTERS/Chris J. Ratcliffe/File Photo Purchase Licensing Rights, opens new tab Companies GSK plc US FDA approves GSK's drug for liver disease-related itching | Reuters Skip to main content The company did not immediately respond to Reuters request for comment on pricing and availability details. Reporting by Sriparna Roy an ...